AmerisourceBergen Boosts FY22 Profit Outlook As Q3 Beat Expectations
AmerisourceBergen Corp’s (NYSE:ABC) Q3 FY22 adjusted EPS reached $2.62, up 21.3% Y/Y, beating the consensus of $2.57. Revenue of $60.1…
Regeneron’s Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned $9.77 per share for Q2 FY22, down 62% Y/Y, beating the $9.54 estimate. Sales decreased…
Merrimack Pharma-Ipsen’s Cancer Drug Fails In Overall Survival Measure
Merrimack Pharmaceuticals Inc’s (NASDAQ:MACK) partner announced that Ipsen SA (OTC:IPSEY) reported a primary analysis of the results of the…
Horizon Therapeutics’ Shares Tumble On Q2 Miss, Trimmed FY22 Outlook
Horizon Therapeutics plc’s (NASDAQ:HZNP) reported Q2 sales of $876.4 million, +5% Y/Y, missing the consensus of $936.10 million. The adjusted…
Owens & Minor Shares Slip On FY22 Outlook Cut
Owens & Minor Inc (NYSE:OMI) reported second-quarter revenue of $2.50 billion, an increase of 0.44% year-over-year, missing the consensus of…
Alnylam Shares Shoot Higher Following Positive Clinical Results From Late-Stage ATTR Amyloidosis Therapeutics
Alnylam (NASDAQ: ALNY) announced positive results from the APOLLO-B Phase 3 study of Patisiran for the treatment of transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.
FDA Accepts MediWound’s Refiling For Severe Thermal Burns Therapy For Review
The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ: MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns.
Tupperware Brands Shares Rip After Huge Q2 EPS Beat
Tupperware Brands Corp (NYSE:TUP) reported a second-quarter FY22 sales decline of 18% year-on-year to $340.40 million, beating the consensus of $330.20…
Nasdaq, S&P 500 Shrug Off Hawkish Fed Talk As Earnings Season Reaches Its Peak
Nasdaq and S&P 500 were moving higher Wednesday morning despite hawkish comments from St. Louis Federal Reserve President James Bullard Tuesday evening. If the markets do close higher today, it would snap a two-day losing streak to start the week.